Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/autre/pyrantel-parasiticide-therapy-in-humans-and-domestic-animals/descriptif_3780919
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=3780919

Pyrantel Parasiticide Therapy in Humans and Domestic Animals

Langue : Anglais

Coordonnateur : Marchiondo Alan A.

Couverture de l’ouvrage Pyrantel Parasiticide Therapy in Humans and Domestic Animals

Pyrantel Parasiticide Therapy in Humans and Domestic Animals presents a single source history and reference on the parasiticide activity and pharmacology of the tetrahydropyrimidines and their salts in humans and domestic animals, also collating evidence that resistance to pyrantel has developed in human and domestic animal nematodes.

Other books of this nature have been compiled historically for specific anthelmintic compounds, but none has been written to date for the pyrantel family of drugs. Pyrantel, a nicotinic receptor agonist, has been used in domestic animal and human medicine since the 1970?s to control two important nematode groups, the hookworms and the roundworms.

Given the zoonotic potential of these parasites, pyrantel has served a dual role in helping to protect the health of both domestic animals and the public for more than 45 years.

Preface
Introduction
History of the Discovery and Chemistry of Pyrantel, Oxantel, and Morantel
Pharmacology and Anthelmintic Resistance
Safety of Pyrantel, Oxantel and Morantel
Formulations and Clinical Uses of Pyrimidine Compounds in Domestic Animals
Pyrantel in Human Anthelmintic Therapy
Unmet needs and Concluding Remarks
• American Association of Veterinary Parasitologists (AAVP) President 2012-2013
• AAVP Vice-President 2010-2011
• AAVP President-Elect & Program Chair, 2011-2012
• AAVP Secretary/Treasurer 2004-2010
• AAVP Program Administrator and Executive Secretary, 2014-Present
• Editorial Board Member - Veterinary Parasitology, 1988-Present
• 30-year career in the animal health industry
• 50+ Publication in Peer reviewed Scientific Journals
• Edmonds. M.D., Vatta, A.F., Marchiondo, A.A., Vanimisetti, H.B., Edmonds, J.D. 2018. Concurrent treatment with a macrocyclic lactone and benzimidazoles provides season long performance advantages in grazing cattle harboring macrocyclic lactone resistant nematodes. Vet Parasitol 252:157-162.
• Ballweber, L.R., Beugnet, F., Marchiondo, A.A., Payne, P.A. 2014. American Association of Veterinary Parasitologists’ review of veterinary fecal flotation methods and factors influencing their accuracy and use – Is there really one best technique? Vet Parasitol 204:73-80.
• Riviere, J.E., Brooks, J.D., Collard, W.T., Deng, J., de Rose, G., Mahabir, S.P., Merritt, D.A., Marchiondo, A.A. 2014. Prediction of formulation effects on dermal absorption of topically applied ectoparasiticides dosed in vitro on canine and porcine skin using a mixture-adjusted quantitative structure permeability relationship. J Vet Pharm Therap 37 (5):435-444.
• Marchiondo, A.A., Holdsworth, P.A., Fourie, L.J., Rugg, D., Hellman, K., Synder, D.E., Dryden, M.W. 2013. World Association for the Advancement of Veterinary Parasitology: W.A.A.V.P. second edition: Guidelines for evaluating the efficacy of parasiticides for the treatment, prevention and control of flea and tick infestations on dogs and cats. Vet Parasitol 194:84-97.
• Campbell, W.C., Conder G.A, Marchiondo A.A. 2009. Future of the animal health industry at a time of food crisis. Vet Parasitol 163 (3): 188-195.
• Marchiondo, A.A., Holdsworth, P.A., Green, P., Blagburn, B.L., Jacob
  • Easy-to-use reference guide on the anthelmintic pyrantel for clinicians, parasitologists, and researchers in human and veterinary medicine
  • Addresses current issues of resistance, along with combination uses against anthelmintic resistant parasites
  • Presents useful, authoritative information (chemical, pharmaceutical, clinical, etc.) for the pyrantel family of compounds
  • Includes a discussion on pyrantel’s potential role in combination therapies
  • Provides cutting-edge material, and will be an evolving area of scientific discussion of treatment options in the future

Date de parution :

Ouvrage de 158 p.

15x22.8 cm

Disponible chez l'éditeur (délai d'approvisionnement : 14 jours).

72,84 €

Ajouter au panier